Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11007679 | Cancer Epidemiology | 2018 | 10 Pages |
Abstract
Contrary to current practice, we recommend that all the stage information should be used in surveillance. Patients missing stage should also be included to minimise bias. Combined data on stage and emergency presentation could be used to create summary prognostic measures. More work is needed to create statistics based on the diagnostic interval that will be useful for surveillance.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Patrick Muller, Sarah Walters, Michel P. Coleman, Laura Woods,